<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shuman, Jill</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Verma, Atul</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The Role of Asymptomatic AF on Postablation Outcomes</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">24-24</style></pages><abstract><style  face="normal" font="default" size="100%">Atrial fibrillation (AF) is responsible for substantial morbidity, including stroke. While catheter ablation has emerged as an effective treatment for symptomatic AF [Stabile G et al. Eur Heart J 2006], less is known about the incidence of either pre- or postablation asymptomatic AF [Rho RW, Page RL. Prog Cardiovasc Dis 2005]. This article discusses results from the Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation Before and After Catheter Ablation trial [DISCERN AF; Verma A et al. JAMA Intern Med 2013].</style></abstract><number><style face="normal" font="default" size="100%">21</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>